Fresenius Kabi USA has announced the immediate availability of 4 ml vials of 20% acetylcysteine solution for inhalation. The company has offered 10 ml vials since 2012 and 30 ml vials since 2013. Acetylcysteine solution for inhalation, a mucolytic agent, had been in short supply in the US since 2011.
Several manufacturers, including Ben Venue and American Regent/Luitpold have ceased production of acetylcysteine solution, and Ben Venue recently recalled one of its remaining lots of 10% solution due to glass contamination.
Fresenius Kabi and Hospira, however, both have product available, and the FDA has declared the shortage of acetylcysteine solution resolved as of February 18, 2014.
Read the Fresenius Kabi press release.
